The human endogenous retrovirus envelope glycoprotein, syncytin-1, regulates neuroinflammation and its receptor expression in multiple sclerosis: A role for endoplasmic reticulum chaperones in astrocytes

Journal of Immunology

Volumn 179, Issue 2, 2007, Pages 1210-1224

  Antony, Joseph M ^a   Ellestad, Kristofor K ^e   Hammond, Robert ^b   Imaizumi, Kazunori ^c   Mallet, François ^d   Warren, Kenneth G ^e   Power, Christopher ^a,e  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF MIYAZAKI   (Japan)

^d UNIVERSITÉ DE LYON   (France)

^e UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSPORTER; CYTOTOXIN; EARLY GROWTH RESPONSE FACTOR 1; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOPROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MYELIN PROTEIN; SMALL INTERFERING RNA; SYNCYTIN 1; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; CHAPERONE; CREB3L1 PROTEIN, HUMAN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; NERVE PROTEIN; NITRIC OXIDE SYNTHASE; PLACENTA PROTEIN; SLC1A4 PROTEIN, HUMAN; SYNCYTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BRAIN TISSUE; CELL CULTURE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CORPUS CALLOSUM; DOWN REGULATION; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; GLIA CELL; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRUS; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; BIOSYNTHESIS; BRAIN; CELL LINE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; METABOLISM; PATHOLOGY; PROTEIN MICROARRAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AMINO ACID TRANSPORT SYSTEM ASC; ANIMALS; ASTROCYTES; BLOTTING, WESTERN; BRAIN; CELL LINE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; ENDOPLASMIC RETICULUM; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE PRODUCTS, ENV; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MICE; MICE, TRANSGENIC; MOLECULAR CHAPERONES; MULTIPLE SCLEROSIS; NERVE TISSUE PROTEINS; NITRIC OXIDE SYNTHASE; OLIGODENDROGLIA; PREGNANCY PROTEINS; PROTEIN ARRAY ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 34548744695     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.2.1210     Document Type: Article

References (87)

1. Frohman, E. M., M. K. Racke, and C. S. Raine. 2006. Multiple sclerosis-the plaque and its pathogenesis. N. Engl. J. Med. 354: 942-955.
2. Hartung, H. P., and P. Rieckmann. 1997. Pathogenesis of immune-mediated demyelination in the CNS. J. Neural. Transm. 50(Suppl.): 173-181.
3. Custer, S. K., G. A. Garden, N. Gill, U. Rueb, R. T. Libby, C. Schultz, S. J. Guyenet, T. Deller, L. E. Westrum, B. L. Sopher, and A. R. La Spada. 2006. Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport. Nat. Neurosci. 9: 1302-1311.
4. Lavillette, D., M. Marin, A. Ruggieri, F. Mallet, F. L. Cosset, and D. Kabat. 2002. The envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters/cell surface receptors. J. Virol. 76: 6442-6452.
5. Dolinska, M., B. Zablocka, U. Sonnewald, and J. Albrecht. 2004. Glutamine uptake and expression of mRNA's of glutamine transporting proteins in mouse cerebellar and cerebral cortical astrocytes and neurons. Neurochem. Int. 44: 75-81.
6. Yamamoto, T., I. Nishizaki, T. Nukada, E. Kamegaya, S. Furuya, Y. Hirabayashi, K. Ikeda, H. Hata, H. Kobayashi, I. Sora, and H. Yamamoto. 2004. Functional identification of ASCT1 neutral amino acid transporter as the predominant system for the uptake of L-serine in rat neurons in primary culture. Neurosci. Res. 49: 101-111.
7. Weiss, M. D., C. Rossignol, C. Sumners, and K. J. Anderson. 2005. A pH-dependent increase in neuronal glutamate efflux in vitro: possible involvement of ASCT1. Brain Res. 1056: 105-112.
8. Blond, J. L., D. Lavillette, V. Cheynet, O. Bouton, G. Oriol, S. Chapel-Fernandes, B. Mandrand, F. Mallet, and F. L. Cosset. 2000. An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J. Virol. 74: 3321-3329.
9. Ruprecht, K., K. Obojes, V. Wengel, F. Gronen, K. S. Kim, H. Perron, J. Schneider-Schaulies, and P. Rieckmann. 2006. Regulation of human endogenous retrovirus W protein expression by herpes simplex virus type 1: implications for multiple sclerosis. J. Neurovirol. 12: 65-71.
10. Antony, J. M., M. Izad, A. Bar-Or, M. Vodjgani, K. G. Warren, and C. Power. 2006. Quantitative analysis of human endogenous retrovirus-W env in neuroinflammatory diseases. AIDS Res. Hum. Retroviruses 22: 1253-1259.
11. Mameli, G., V. Astone, K. Khalili, C. Serra, B. E. Sawaya, and A. Dolei. 2007. Regulation of the syncytin-1 promoter in human astrocytes by multiple sclerosis-related cytokines. Virology 362: 120-130.
12. Antony, J. M., G. van Marle, W. Opii, D. A. Butterfield, F. Mallet, V. W. Yong, J. L. Wallace, R. M. Deacon, K. Warren, and C. Power. 2004. Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat. Neurosci. 7: 1088-1095.
13. Sasaki, H., H. Sato, K. Kuriyama-Matsumura, K. Sato, K. Maebara, H. Wang, M. Tamba, K. Itoh, M. Yamamoto, and S. Bannai. 2002. Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression. J. Biol. Chem. 277: 44765-44771.
14. Qiang, W., J. M. Cahill, J. Liu, X. Kuang, N. Liu, V. L. Scofield, J. R. Voorhees, A. J. Reid, M. Yan, W. S. Lynn, and P. K. Wong. 2004. Activation of transcription factor Nrf-2 and its downstream targets in response to moloney murine leukemia virus ts1-induced thiol depletion and oxidative stress in astrocytes. J. Virol. 78: 11926-11938.
15. Lin, W., A. Kemper, J. L. Dupree, H. P. Harding, D. Ron, and B. Popko. 2006. Interferon-γ inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress. Brain 129: 1306-1318.
16. Kaufman, R. J. 1999. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev. 13: 1211-1213.
17. Rao, R. V., and D. E. Bredesen. 2004. Misfolded proteins, endoplasmic reticulum stress and neurodegeneration. Curr. Opin. Cell. Biol. 16: 653-662.
18. Mycko, M. P., R. Papoian, U. Boschert, C. S. Raine, and K. W. Selmaj. 2004. Microarray gene expression profiling of chronic active and inactive lesions in multiple sclerosis. Clin. Neurol. Neurosurg. 106: 223-229.
19. Bauer, J., M. Bradl, M. Klein, M. Leisser, T. L. Deckwerth, H. Wekerle, and H. Lassmann. 2002. Endoplasmic reticulum stress in PLP-overexpressing transgenic rats: gray matter oligodendrocytes are more vulnerable than white matter oligodendrocytes. J. Neuropathol. Exp. Neurol. 61: 12-22.
20. Michel, N., I. Allespach, S. Venzke, O. T. Fackler, and O. T. Keppler. 2005. The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface CCR5 and CD4. Curr. Biol. 15: 714-723.
21. Wang, H., E. Klamo, S. E. Kuhmann, S. L. Kozak, M. P. Kavanaugh, and D. Kabat. 1996. Modulation of ecotropic murine retroviruses by N-linked glycosylation of the cell surface receptor/amino acid transporter. J. Virol. 70: 6884-6891.
22. Qiang, W., X. Kuang, J. Liu, N. Liu, V. L. Scofield, A. J. Reid, Y. Jiang, G. Stoica, W. S. Lynn, and P. K. Wong. 2006. Astrocytes survive chronic infection and cytopathic effects of the ts1 mutant of the retrovirus Moloney murine leukemia virus by upregulation of antioxidant defenses. J. Virol. 80: 3273-3284.
23. Kim, H. T., K. Waters, G. Stoica, W. Qiang, N. Liu, V. L. Scofield, and P. K. Wong. 2004. Activation of endoplasmic reticulum stress signaling pathway is associated with neuronal degeneration in MoMuLV-ts1-induced spongiform encephalomyelopathy. Lab. Invest. 84: 816-827.
24. Dimcheff, D. E., S. Askovic, A. H. Baker, C. Johnson-Fowler, and J. L. Portis. 2003. Endoplasmic reticulum stress is a determinant of retrovirus-induced spongiform neurodegeneration. J. Virol. 77: 12617-12629.
25. Dimcheff, D. E., M. A. Faasse, F. J. McAtee, and J. L. Portis. 2004. Endoplasmic reticulum (ER) stress induced by a neurovirulent mouse retrovirus is associated with prolonged BiP binding and retention of a viral protein in the ER. J. Biol. Chem. 279: 33782-33790.
26. Clase, A. C., D. E. Dimcheff, C. Favara, D. Dorward, F. J. McAtee, L. E. Parrie, D. Ron, and J. L. Portis. 2006. Oligodendrocytes are a major target of the toxicity of spongiogenic murine retroviruses. Am. J. Pathol. 169: 1026-1038.
27. Johnston, J. B., C. Silva, J. Holden, K. G. Warren, A. W. Clark, and C. Power. 2001. Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases. Ann. Neurol. 50: 434-442.
28. Katsumata, K., H. Ikeda, M. Sato, A. Ishizu, Y. Kawarada, H. Kato, A. Wakisaka, T. Koike, and T. Yoshiki. 1999. Cytokine regulation of env gene expression of human endogenous retrovirus-R in human vascular endothelial cells. Clin. Immunol. 93: 75-80.
29. Perron, H., F. Lazarini, K. Ruprecht, C. Pechoux-Longin, D. Seilhean, V. Sazdovitch, A. Creange, N. Battail-Poirot, G. Sibai, L. Santoro, et al. 2005. Human endogenous retrovirus (HERV)-W ENV and GAG proteins: physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesions. J. Neurovirol. 11: 23-33.
30. Xu, W., L. Liu, I. G. Charles, and S. Moncada. 2004. Nitric oxide induces coupling of mitochondrial signalling with the endoplasmic reticulum stress response. Nat. Cell Biol. 6: 1129-1134.
31. Kondo, S., T. Murakami, K. Tatsumi, M. Ogata, S. Kanemoto, K. Otori, K. Iseki, A. Wanaka, and K. Imaizumi. 2005. OASIS, a CREB/ATF-family member, modulates UPR signalling in astrocytes. Nat. Cell. Biol. 7: 186-194.
32. Tsutsui, S., J. Schnermann, F. Noorbakhsh, S. Henry, V. W. Yong, B. W. Winston, K. Warren, and C. Power. 2004. A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. J. Neurosci. 24: 1521-1529.
33. Power, C., S. Henry, M. R. Del Bigio, P. H. Larsen, D. Corbett, Y. Imai, V. W. Yong, and J. Peeling. 2003. Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases. Ann. Neurol. 53: 731-742.
34. Power, C., P. A. Kong, T. O. Crawford, S. Wesselingh, J. D. Glass, J. C. McArthur, and B. D. Trapp. 1993. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann. Neurol. 34: 339-350.
35. Power, C., P. A. Kong, and B. D. Trapp. 1996. Major histocompatibility complex class I expression in oligodendrocytes induces hypomyelination in transgenic mice. J. Neurosci. Res. 44: 165-173.
36. Yong, V. W. A. J. 1997. Culture of glial cells from human brain biopsies. In Protocols for Neural Cell Culture. R. A. Fedoroff S, ed. Humana, Totowa, pp. 81-96.
37. Riches, D. W., and G. A. Underwood. 1991. Expression of interferon-β during the triggering phase of macrophage cytocidal activation: evidence for an autocrine/ paracrine role in the regulation of this state. J. Biol. Chem. 266: 24785-24792.
38. Zhang, K., F. Rana, C. Silva, J. Ethier, K. Wehrly, B. Chesebro, and C. Power. 2003. Human immunodeficiency virus type 1 envelope-mediated neuronal death: uncoupling of viral replication and neurotoxicity. J. Virol. 77: 6899-6912.
39. Stalder, A. K., M. J. Carson, A. Pagenstecher, V. C. Asensio, C. Kincaid, M. Benedict, H. C. Powell, E. Masliah, and I. L. Campbell. 1998. Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor. Am. J. Pathol. 153: 767-783.
40. Cheynet, V., A. Ruggieri, G. Oriol, J. L. Blond, B. Boson, L. Vachot, B. Verrier, F. L. Cosset, and F. Mallet. 2005. Synthesis, assembly, and processing of the Env ERVWE1/syncytin human endogenous retroviral envelope. J. Virol. 79: 5585-5593.
41. Guenther, K., R. M. Deacon, V. H. Perry, and J. N. Rawlins. 2001. Early behavioural changes in scrapie-affected mice and the influence of dapsone. Eur. J. Neurosci. 14: 401-409.
42. Boston-Howes, W., S. L. Gibb, E. O. Williams, P. Pasinelli, R. H. Brown, Jr., and D. Trotti. 2006. Caspase-3 cleaves and inactivates the glutamate transporter EAAT2. J. Biol. Chem. 281: 14076-14084.
43. Rolland, A., E. Jouvin-Marche, C. Viret, M. Faure, H. Perron, and P. N. Marche. 2006. The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses. J. Immunol. 176: 7636-7644.
44. Gegelashvili, M., A. Rodriguez-Kern, I. Pirozhkova, J. Zhang, L. Sung, and G. Gegelashvili. 2006. High-affinity glutamate transporter GLAST/EAAT1 regulates cell surface expression of glutamine/neutral amino acid transporter ASCT2 in human fetal astrocytes. Neurochem. Int. 48: 611-615.
45. Chen, C. P., K. G. Wang, C. Y. Chen, C. Yu, H. C. Chuang, and H. Chen. 2006. Altered placental syncytin and its receptor ASCT2 expression in placental development and pre-eclampsia. BJOG 113: 152-158.
46. Marin, M., D. Lavillette, S. M. Kelly, and D. Kabat. 2003. N-linked glycosylation and sequence changes in a critical negative control region of the ASCT1 and ASCT2 neutral amino acid transporters determine their retroviral receptor functions. J. Virol. 77: 2936-2945.
47. An, D. S., Y. Xie, and I. S. Chen. 2001. Envelope gene of the human endogenous retrovirus HERV-W encodes a functional retrovirus envelope. J. Virol. 75: 3488-3489.
48. Lock, C., G. Hermans, R. Pedotti, A. Brendolan, E. Schadt, H. Garren, A. Langer-Gould, S. Strober, B. Cannella, J. Allard, et al. 2002. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8: 500-508.
49. Noorbakhsh, F., Q. Tang, S. Liu, C. Silva, G. van Marle, and C. Power. 2006. Lentivirus envelope protein exerts differential neuropathogenic effects depending on the site of expression and target cell. Virology 348: 260-276.
50. Mattson, M. P., and D. D. Taub. 2004. Ancient viral protein enrages astrocytes in multiple sclerosis. Nat. Neurosci. 7: 1021-1023.
51. Sato, H., M. Tamba, K. Kuriyama-Matsumura, S. Okuno, and S. Bannai. 2000. Molecular cloning and expression of human xCT, the light chain of amino acid transport system xc. Antioxid. Redox. Signal 2: 665-671.
52. Kanai, Y., and H. Endou. 2001. Heterodimeric amino acid transporters: molecular biology and pathological and pharmacological relevance. Curr. Drug Metab. 2: 339-354.
53. Qin, S., C. Colin, I. Hinners, A. Gervais, C. Cheret, and M. Mallat. 2006. System Xc- and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-β peptide 1-40. J. Neurosci. 26: 3345-3356.
54. Murakami, T., S. Kondo, M. Ogata, S. Kanemoto, A. Saito, A. Wanaka, and K. Imaizumi. 2006. Cleavage of the membrane-bound transcription factor OASIS in response to endoplasmic reticulum stress. J. Neurochem. 96: 1090-1100.
55. Bhat, N. R., D. L. Feinstein, Q. Shen, and A. N. Bhat. 2002. p38 MAPK-mediated transcriptional activation of inducible nitric-oxide synthase in glial cells: roles of nuclear factors, nuclear factor κ-B, cAMP response element-binding protein, CCAAT/enhancer-binding protein-β, and activating transcription factor-2. J. Biol. Chem. 277: 29584-29592.
56. Barnett, M. H., and J. W. Prineas. 2004. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann. Neurol. 55: 458-468.
57. Kuhlmann, T., C. Lucchinetti, U. K. Zettl, A. Bitsch, H. Lassmann, and W. Bruck. 1999. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions. Glia 28: 34-39.
58. Noorbakhsh, F., S. Tsutsui, N. Vergnolle, L. A. Boven, N. Shariat, M. Vodjgani, K. G. Warren, P. Andrade-Gordon, M. D. Hollenberg, and C. Power. 2006. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J. Exp. Med. 203: 425-435.
59. +-dependent anion leak. J. Physiol. 557: 747-759.
60. Bo, L., T. M. Dawson, S. Wesselingh, S. Mork, S. Choi, P. A. Kong, D. Hanley, and B. D. Trapp. 1994. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36: 778-786.
61. Kanai, Y., and M. A. Hediger. 2004. The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects. Pflugers Arch. 447: 469-479.
62. Rupprecht, H. D., Y. Akagi, A. Keil, and G. Hofer. 2000. Nitric oxide inhibits growth of glomerular mesangial cells: role of the transcription factor EGR-1. Kidney Int. 57: 70-82.
63. Coombs, B. D., A. Best, M. S. Brown, D. E. Miller, J. Corboy, M. Baier, and J. H. Simon. 2004. Multiple sclerosis pathology in the normal and abnormal appearing white matter of the corpus callosum by diffusion tensor imaging. Mult. Scler. 10: 392-397.
64. Zhang, L., W. Zhao, B. Li, D. L. Alkon, J. L. Barker, Y. H. Chang, M. Wu, and D. R. Rubinow. 2000. TNF-α induced over-expression of GFAP is associated with MAPKs. Neuroreport 11: 409-412.
65. Kawahara, K., S. Oyadomari, T. Gotoh, S. Kohsaka, H. Nakayama, and M. Mori. 2001. Induction of CHOP and apoptosis by nitric oxide in p53-deficient microglial cells. FEBS Lett. 506: 135-139.
66. Prat, A., and J. Antel. 2005. Pathogenesis of multiple sclerosis. Curr. Opin. Neurol. 18: 225-230.
67. Trapp, B. D. 2004. Pathogenesis of multiple sclerosis: the eyes only see what the mind is prepared to comprehend. Ann. Neurol. 55: 455-457.
68. Volterra, A., and J. Meldolesi. 2005. Astrocytes, from brain glue to communication elements: the revolution continues. Nat. Rev. Neurosci. 6: 626-640.
69. Zhang, K., X. Shen, J. Wu, K. Sakaki, T. Saunders, D. T. Rutkowski, S. H. Back, and R. J. Kaufman. 2006. Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response. Cell 124: 587-599.
70. Ponferrada, V. G., B. S. Mauck, and D. P. Wooley. 2003. The envelope glycoprotein of human endogenous retrovirus HERV-W induces cellular resistance to spleen necrosis virus. Arch. Virol. 148: 659-675.
71. Kekuda, R., P. D. Prasad, Y. J. Fei, V. Torres-Zamorano, S. Sinha, T. L. Yang-Feng, F. H. Leibach, and V. Ganapathy. 1996. Cloning of the sodium-dependent, broad-scope, neutral amino acid transporter Bo from a human placental choriocarcinoma cell line. J. Biol. Chem. 271: 18657-18661.
72. Sakai, K., H. Shimizu, T. Koike, S. Furuya, and M. Watanabe. 2003. Neutral amino acid transporter ASCT1 is preferentially expressed in L-Ser-synthetic/storing glial cells in the mouse brain with transient expression in developing capillaries. J. Neurosci. 23: 550-560.
73. Hackel, D. 2005. Activation of microglia by injured neurons-signal pathways of oxidatively modified lipids. PhD thesis, Otto von Guericke University of Magdeburg, Magdeburg, Magdeburg, p. 169.
74. +-dependent neutral amino acid transporter ASCT2 by S-nitrosothiols and nitric oxide in Caco-2 cells. FEBS Lett. 579: 2499-2506.
75. Dickhout, J. G., G. S. Hossain, L. M. Pozza, J. Zhou, S. Lhotak, and R. C. Austin. 2005. Peroxynitrite causes endoplasmic reticulum stress and apoptosis in human vascular endothelium: implications in atherogenesis. Arterioscler. Thromb. Vasc. Biol. 25: 2623-2629.
76. Tatarowicz, W. A., C. E. Martin, A. S. Pekosz, S. L. Madden, F. J. Rauscher, 3rd, S. Y. Chiang, T. A. Beerman, and N. W. Fraser. 1997. Repression of the HSV-1 latency-associated transcript (LAT) promoter by the early growth response (EGR) proteins: involvement of a binding site immediately downstream of the TATA box. J. Neurovirol. 3: 212-224.
77. 2: role of early growth response protein-1 (Egr-1). Osteoarthritis Cartilage 7: 395-398.
78. Korner, H., D. S. Riminton, D. H. Strickland, F. A. Lemckert, J. D. Pollard, and J. D. Sedgwick. 1997. Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J. Exp. Med. 186: 1585-1590.
79. FitzGerald, U. F., T. Gilbey, S. Brodie, and S. C. Barnett. 2003. Transcription factor expression and cellular redox in immature oligodendrocyte cell death: effect of Bcl-2. Mol. Cell. Neurosci. 22: 516-529.
80. +-dependent glutamate/aspartate transporter from rat brain. Proc. Natl. Acad. Sci. USA 89: 10955-10959.
81. Yamamoto, T., I. Nishizaki, S. Furuya, Y. Hirabayashi, K. Takahashi, S. Okuyama, and H. Yamamoto. 2003. Characterization of rapid and high-affinity uptake of L-serine in neurons and astrocytes in primary culture. FEBS Lett. 548: 69-73.
82. Sundaram, K. S., and M. Lev. 1984. Inhibition of sphingolipid synthesis by cycloserine in vitro and in vivo. J. Neurochem. 42: 577-581.
83. Furuya, S., and M. Watanabe. 2003. Novel neuroglial and glioglial relationships mediated by L-serine metabolism. Arch. Histol. Cytol. 66: 109-121.
84. Saccani, A., S. Saccani, S. Orlando, M. Sironi, S. Bernasconi, P. Ghezzi, A. Mantovani, and A. Sica. 2000. Redox regulation of chemokine receptor expression. Proc. Natl. Acad. Sci. USA 97: 2761-2766.
85. Ramakrishna, C., C. C. Bergmann, K. V. Holmes, and S. A. Stohlman. 2004. Expression of the mouse hepatitis virus receptor by central nervous system microglia. J. Virol. 78: 7828-7832.
86. Jana, M., and K. Pahan. 2005. Redox regulation of cytokine-mediated inhibition of myelin gene expression in human primary oligodendrocytes. Free Radic. Biol. Med. 39: 823-831.
87. Sriram, S., and I. Steiner. 2005. Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis. Ann. Neurol. 58: 939-945.